MoneyWorks4Me

Ajanta Pharma informs about board meeting

27 Apr 2023 Evaluate

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 5th May 2023 to consider and approve: Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2023 and Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..